We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
(+7.8%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$37.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$29.3M |
| 3 |
Biogen
BIIB
|
+$27.4M |
| 4 |
Home Depot
HD
|
+$22.7M |
| 5 |
Cisco
CSCO
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$23.6M |
| 2 |
TJX Companies
TJX
|
+$19.3M |
| 3 |
FedEx
FDX
|
+$16.4M |
| 4 |
Intuit
INTU
|
+$14.7M |
| 5 |
Corning
GLW
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.18% |
| 2 | Technology | 17.19% |
| 3 | Financials | 12.85% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.95T
| $147M | 2.33% |
1,490,158
-5,881
| -0.4% | -$570K |
|
2
Amazon
AMZN
$2.66T
| $129M | 2.05% |
1,520,920
+208,800
| +16% | +$16.6M |
|
3
Amgen
AMGN
$198B
| $128M | 2.03% |
694,488
+51,039
| +8% | +$9.03M |
|
4
Apple
AAPL
$4.81T
| $124M | 1.96% |
2,682,472
+76,044
| +3% | +$3.45M |
|
5
Alphabet (Google) Class A
GOOGL
$4.24T
| $119M | 1.88% |
2,108,280
+283,000
| +16% | +$15.4M |
|
6
Alibaba
BABA
$283B
| $114M | 1.8% |
613,692
+11,554
| +2% | +$2.2M |
|
7
Meta Platforms (Facebook)
META
$1.63T
| $97.4M | 1.54% |
500,959
-49,915
| -9% | -$9.02M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $88.6M | 1.4% |
1,115,979
+188,302
| +20% | +$15.6M |
|
|
9
Biogen
BIIB
$30B
| $87.8M | 1.39% |
302,642
+97,482
| +48% | +$27.4M |
|
10
ExxonMobil
XOM
$629B
| $78.2M | 1.24% |
944,720
+111,790
| +13% | +$8.91M |
|
11
Regeneron Pharmaceuticals
REGN
$70.8B
| $65.1M | 1.03% |
188,583
+58,963
| +45% | +$18.4M |
|
12
Gilead Sciences
GILD
$162B
| $63.9M | 1.01% |
901,665
+136,064
| +18% | +$9.61M |
|
|
13
Home Depot
HD
$331B
| $63.7M | 1.01% |
326,315
+121,280
| +59% | +$22.7M |
|
14
Visa
V
$677B
| $62.9M | 1% |
474,871
+39,938
| +9% | +$5.14M |
|
15
Procter & Gamble
PG
$345B
| $59.9M | 0.95% |
767,492
+65,792
| +9% | +$4.95M |
|
16
Vertex Pharmaceuticals
VRTX
$122B
| $55.5M | 0.88% |
326,806
+23,333
| +8% | +$3.62M |
|
|
17
JPMorgan Chase
JPM
$918B
| $53.8M | 0.85% |
516,573
-214,889
| -29% | -$23.6M |
|
|
18
Bristol-Myers Squibb
BMY
$124B
| $53M | 0.84% |
958,545
+543,285
| +131% | +$29.3M |
|
19
Johnson & Johnson
JNJ
$603B
| $51.5M | 0.82% |
424,493
+5,223
| +1% | +$652K |
|
20
AbbVie
ABBV
$452B
| $47.5M | 0.75% |
512,384
+180,525
| +54% | +$17.6M |
|
|
21
Cisco
CSCO
$442B
| $47.1M | 0.75% |
1,094,838
+481,888
| +79% | +$21.1M |
|
22
Walt Disney
DIS
$167B
| $44M | 0.7% |
420,054
-47,853
| -10% | -$4.89M |
|
23
Verizon
VZ
$183B
| $42.7M | 0.68% |
847,740
+41,942
| +5% | +$2.03M |
|
24
AT&T
T
$155B
| $42.3M | 0.67% |
1,743,777
+178,264
| +11% | +$4.47M |
|
25
UnitedHealth
UNH
$396B
| $41.1M | 0.65% |
167,483
+19,272
| +13% | +$4.63M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2018 Portfolio in Review
As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.
- Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
- Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
- Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
- Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
- Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
- Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
- Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.
Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.